Review Article

Epidemiology of Alzheimer’s Disease and Dementia in Arab Countries: A Systematic Review

Table 1

Studies of dementia prevalence.

AuthorYearCountryStudy designCriteria used for dementia identificationCut-offs used for dementia diagnosisSample sizeSetting/sampling techStudy key findings

Farrag et al. [17]1998Egypt (Assiut governorate)3-phase cross-sectionalpopulation-basedstudyModified MMSE
Clinical diagnosis
Lab investigations
Positive
Subjects scored 21 or less were eligible to proceed into phase 2 for clinical diagnosis
Negative
Scores 21 to 17 for mild; 16-9 for moderate; less than 9 for severe degrees of dementia
2000Household
Systematic random of total elderly population age years (130,000 subjects)
CPR—4.5 cases per 100 population prevalence:
AD—2.2
Multi-infarct dementia—0.95
Mixed dementia—0.55
Secondary dementias—0.45
Age-specific prevalence tends to double every 5 years after age of 75 years and above
The prevalence of dementia of all types for the age group:
60-64 years: 1.41 %
65-69 years: 1.87 %
70-74 years: 4.06%
75-79 years: 6.46%
80-84 years: 14.87%
85 years or over: 22.01%

El Tallawy et al. [18]2010Egypt (Al Kharga district)Cross-sectionalShort standardized Arabic screening test; MMSEMMSE score: 21–17 for mild, 16–9 for moderate, and <9 for severe degree of dementia8,173Household
All residents (62,583 subjects) of whom 8,173 were of ≥50 years of age
Prevalence:
>50 years—2.26%
>80—18.48%
Dementia subtypes:
AD—51.2%
VaD—28.7%
Due to general medical conditions—12.8%
Due to multiple etiologies—7.3%
Degree of dementia according to
MMSE scores:
Mild—53.7%
Moderate—38.4%
Severe—7.9%

El Tallawy et al.[19]2014Egypt (Al-Quseir city)Cross-sectionalMMSE
Clinical exam investigations
A score of 17-21 for mild, 9-16 for moderate, and less than 9 for a severe degree of dementia4,329Household
All residents (33,285 subjects) of whom, 4,329 were of ≥50 years of age
Total—2.01%
Age:
—.27%
—1.7%
—6.5%
>80—13.5%
Dementia subtypes:
AD—48%
VaD—36%
Due to general medical condition—12%
Due to multiple etiologies—3%

Khedr et al. [20]2015EgyptCross-sectionalMES
MMSE
Neurological examination
MES total score 75–62 appear to be the range for patients with MCI
A score of 17–21 on MMSE for mild, 9–16 for moderate, and less than 9 for a severe degree of dementia
691Household
Multistage random sampling
MCI—1.74 cases per 100 population
Dementia—5.07 cases/100 population
AD—1.74 cases/100 population
VaD—1.3 cases/100 population
Parkinson’s—1.01 cases/100 population

Chahine et al. [21]2006LebanonCross-sectionalMMSE and GDSDementia diagnosed at
25–29—nondemented but with indeterminate cognitive function
Mild, moderate, or severe dementia—20–24, 14–19, <14
Score of 30—normal cognitive function
117Nursing home residents (NSR)
Random
Dementia of some kind found in 61 NSR (59.8%)
Mild dementia in 17 NSR (27.9%)
Moderate dementia in 14 NSR (22.9%)
Severe dementia in 30 NSR (49.2%)
Depression in 45 NSR (57.7%)

Phung et al. [22]2017LebanonCross-sectionalRUDASScores ranging from 0 to 30; higher scores indicate better cognitive function502Household multistage cluster samplingCrude dementia was less prevalent (7.4%) as compared to age-standardized dementia (9%). Based on estimated total number of Lebanese older than 65 years in 2013 (404,274 persons), the estimated number of people with dementia in Lebanon was 29,916 persons

Ghuloum et al. [23]2011QatarCross-sectionalDesigned screening questionnaire
Psychiatric assessment
1660 (297 were >50 yrs)15 primary healthcare clinics
All 18-65 years old
Prevalence:
Total—1.1% (M—1.8, F—.6), above 50 years

Ouanes et al. [24]2014TunisCross-sectionalMoCA testScores on the MoCA range from zero to 30, with a score of 26 and higher generally considered normal77Manouba nursing home
All 116 residents
(mean )
Dementia—45(58.4%)
Only three were already diagnosed

Ghubash et al. [25]2004United Arab Emirates (Dubai, Ras-Al-Khaimah, Al-Ain)Cross-sectionalGMS-A3610Household, random sample of 843 households
(>60 yrs)
Cognitive impairment with or without dementia—3.6%

MMSE: modified mini-mental state examination; CPR: crude prevalence rate; MCI: mild cognitive impairment; VaD: vascular dementia; MES: Memory and Executive Screening test; GDS: Geriatric Depression Scale; NINCDS-ADRDA: National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer’s Disease and Related Disorders Association; NINDSAIREN: National Institute of Neurological Disorders and Stroke (NINDS) and the Association Internationale pour la Recherche et l’Enseignement en Neurosciences; SMQ: short-memory questionnaire; BCST: Brookdale Cognitive Screening Test; A-IQCODE 16: Arabic Version of 16-item Informant Questionnaire on Cognitive Decline for the older adults; DRG: Dementia Research Group; MoCA: Montreal Cognitive Assessment; GMS: Geriatric Mental State Interview; CERAD: Consortium to Establish a Registry of Alzheimer’s Disease; NEUROEX: physical assessment and brief neurological examination; RUDAS: Rowland Universal Dementia Assessment Scale.